Ironwood Pharmaceuticals Inc
SWB:I76
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ironwood Pharmaceuticals Inc
SWB:I76
|
US |
|
ROKMASTER Resources Corp
F:1RR1
|
CA |
|
Valora Effekten Handel AG
F:VEH
|
DE |
|
V
|
Voltaire Leasing and Finance Ltd
BSE:509038
|
IN |
|
M
|
Muto Seiko Co
TSE:7927
|
JP |
|
G
|
Gujarat Intrux Ltd
BSE:517372
|
IN |
|
Digihost Technology Inc
XTSX:DGX
|
CA |
|
W
|
Wins Co Ltd
KOSDAQ:136540
|
KR |
|
B
|
BluGo SA
WSE:YOL
|
PL |
|
E
|
Eureking SA
PAR:KINGS
|
FR |
|
G
|
Goldrea Resources Corp
CNSX:GOR
|
CA |
|
Society Pass Inc
NASDAQ:SOPA
|
US |
|
N
|
Nanso Transport Co Ltd
TSE:9034
|
JP |
Wall St Price Targets
I76 Price Targets Summary
Ironwood Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for I76 is 5.27 EUR with a low forecast of 3.16 EUR and a high forecast of 8.89 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is I76's stock price target?
Price Target
5.27
EUR
According to Wall Street analysts, the average 1-year price target for I76 is 5.27 EUR with a low forecast of 3.16 EUR and a high forecast of 8.89 EUR.
What is the Revenue forecast for Ironwood Pharmaceuticals Inc?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is -3%.
What is the Operating Income forecast for Ironwood Pharmaceuticals Inc?
Projected CAGR
-13%
The compound annual growth rate for Operating Income over the next 8 years is -13%.
What is the Pre-Tax Income forecast for Ironwood Pharmaceuticals Inc?
Projected CAGR
67%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 67%.
What is the Net Income forecast for Ironwood Pharmaceuticals Inc?
Projected CAGR
7%
The compound annual growth rate for Net Income over the next 8 years is 7%.
